Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Device Firms Expect Little From Obamacare Insurance Expansion, But Numbers More Complicated

This article was originally published in The Gray Sheet

Executive Summary

It remains to be seen how many new people end up insured on the Obamacare exchanges, and what the impact will be on device markets. Many executives at implantable companies suggest they will see almost no impact, in part because they get most of their business from Medicare. Government health care statistics, actually suggest a fairly high percentage of under-65-year-old patients get pacemakers, stents, knees and other devices. But there may also be other factors at play.


Related Content

Gain In Procedures For Newly Insured Under Health Reform May Offset Device Tax, Analyst Says


Related Companies




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts